AI-generated · cited to primary sources · not investment advice
Marico (531642) Nov 2025 Filing Analysis
Does management do what it says?
Marico exceeded its FY26 revenue growth target of 25%, delivering a record 26% growth for the full year. (3 exceeded, 2 met across 5 tracked commitments)
“Supported by pricing growth, we continue to target around 25% consolidated revenue growth this year.”
Margin headwinds were severe in Q2FY26, with consolidated EBITDA margins contracting by 350 bps YoY to 16.1% due to hyperinflation in copra. (1 met across 1 tracked commitment)
“EBITDA Margin 16.1% (Q2FY26) vs 19.6% (Q2FY25) Change (350 bps)”
Management reports that Project SETU is yielding visible results in rural reach and execution quality, though the final 1.5mn target is for FY27. (1 in progress across 1 tracked commitment)
“3-Year Phased Plan FY24 1mn Direct reach -> FY27 1.5mn Direct reach”
Target to scale the Digital-first brands exit ARR to approximately 2.5x of FY24 levels by FY27. — target: 2.5x of FY24 ARR (+3 more commitments)
“Exit ARR expected to be ~2.5x of FY24 ARR in FY27 (raised from ~2x previously)”
See the full cited Management analysis of Marico
How durable is the business?
The digital-first portfolio (Premium Personal Care) is expanding rapidly, exiting the quarter with an Annual Revenue Run-rate (ARR) of over Rs. 1,000 crores. The Foods segment saw a temporary growth slowdown to 12% due to strategic consolidation and accounting adjustments on e-commerce platforms. (3 expanding)
“The digital first portfolio exited the quarter with an ARR of over Rs. 1,000 crores... you would have seen that we have grown 12% this quarter [in Foods].”
See the full cited Business Model analysis of Marico
What could break the thesis?
EASING. Management reports 'above-average monsoons' and a 'healthy crop outlook' as positive macro drivers supporting rural income and consumption recovery. (1 easing)
“Above-average Monsoons and Healthy Crop Outlook Supporting rural income and consumption recovery”
See the full cited Risk analysis of Marico
AI-generated informational research only. ThesisLoop is not investment advice, a stock recommendation, or a guarantee of returns.